Anti-Factor XIIIa Ab-2 Polyclonal Antibody, Unconjugated from Lab Vision

Products	Anti-Factor XIIIa Ab-2 Polyclonal Antibody, Unconjugated from Lab Vision
Company	Lab Vision
Item	Anti-Factor XIIIa Ab-2 Polyclonal Antibody, Unconjugated
Price	$139.00
Description	Factor XIII in both reduced and non-reduced forms. It does not react with human Factor XIII B-chain or human Factor XII. Factor XIII is a Beta-globulin found in plasma and is composed of two subunits. Factor XIII-A is the catalytic subunit and is a dimmer of M.W. 160kDa. Factor XIII is present in plasma as an Alpha2Beta2 heterodimer (M.W. 320kDa); whereas in platelets, only the Alpha2 unit exists. Factor XIIIa is a dermal dendrocyte marker and shows variable reaction with these types of tumors. It can be used for histiocytic phenotyping and has been reported to mark capillary hemangiomas and tumors of the central nervous system. Factor XIII has also been used with CD34 to differentiate between dermatofibroma and dermatofibrosarcoma protuberans. Species Reactivity: Human. Others-not tested.
Info	Lab Vision 47777 Warm Springs Blvd. Fremont, CA 94539 Customer Service: 800-828-1628 Fax Number: 510-991-2826 Web Site: http://www.labvision.com

NOTE: Price information is approximate list price and actual prices may vary.

Porcine Aortic Smooth Muscle Cells (PAOSMC) (>500,000 cells)...

... BioControl is a major step forward ... liquid handling system - with one ... cone modules. All five single channel ... fit one handle. The lightweight handle ...

Bovine Pulmonary Artery Smooth Muscle Cells (BPASMC) (>500,000 cells)...

... known as smooth muscle cell specific protein, is ... various tissues such as intestine, lung and uterus. ... calponin. SM22 alpha expression has been reported in ... vascular and visceral forms. It is also reported ...

Biology Products:

PAOSMC (P354-05) from European Collection of Cell Cultures (ECACC)Finnpipette BioControl Single Channel, 40-200ul from Thermo Scientific BPASMC (B352-05) from European Collection of Cell Cultures (ECACC)Mouse Anti-Human SM22 alpha Monoclonal Antibody, Unconjugated Conjugated, Clone 10H12 from Vision BioSystems

(Date:7/10/2014)... Aware, Inc. (NASDAQ: AWRE ), a ... on June 26, 2014 that its Board of Directors ... share, or approximately $40 million in total. The Board ... a payment date of July 24, 2014. The Company ... an ex-dividend date for this special cash dividend. An ...

(Date:7/10/2014)... , July 2, 2014 Unisys Corporation,s (NYSE: ... Unisys Nederland N.V., today announced that it has been selected ... and manage a new Basic Provision Biometrics solution for penitentiaries ... Unisys won the contract with a solution based on its ... The term of the contract is up to seven years, ...

(Date:7/10/2014)... July 2, 2014 NXT-ID, Inc., (OTCQB: NXTD) a biometric authentication ... Mr. Gino Pereira was interviewed on July 1 ... Tampa Florida . Mr. Pereira discusses the company,s ... Harris and how the Wocket™ aims to replace a ... Cedric Harris tells Gino he has never ...

Breaking Biology News(10 mins):NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share 2 Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 2 Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 3 Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 2 Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 3 Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 4

[0] NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share [0] Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service [0] Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet

... Building on these findings, the Helmholtz scientists and their ... pathogenesic mechanisms of the disease and gain perspectives for ... study have been published online in the journal ... international research consortium QTSCD (QT Interval and Sudden Cardiac ...

... cholesterol level, working out on his treadmill. The ... his heart,s electrical system had managed to stay on the ... sudden cardiac death, which annually claims more than a quarter ... detectable molecules circulating in the blood makes the prediction of ...

... Technology and Innovation in Global BiometricsGAITHERSBURG, Md., March ... ) has been named the Biometrics Systems Integrator ... recognizing the Corporation,s leadership in developing innovative biometrics ... and Sullivan based the award on a rigorous ...

Cached Biology News:Genetic risk factors identified for sudden cardiac death 2 Genetic risk factors identified for sudden cardiac death 3 Hopkins scientists ID 10 genes associated with a risk factor for sudden cardiac death 2 Hopkins scientists ID 10 genes associated with a risk factor for sudden cardiac death 3 Lockheed Martin Named Biometrics 'Company of the Year' by Frost and Sullivan 2

Genetic risk factors identified for sudden cardiac death Hopkins scientists ID 10 genes associated with a risk factor for sudden cardiac death Lockheed Martin Named Biometrics 'Company of the Year' by Frost and Sullivan

(Date:7/11/2014)... MISSISSAUGA, ON , July 11, 2014 /CNW/ - ... Canada approved APTIOM TM (eslicarbazepine acetate) for use ... partial-onset seizures in patients with epilepsy who are not ... not indicated for use in patients under 18 years ... the most common neurological disorders and according to Epilepsy ...

(Date:7/10/2014)... 2014 Women in the West ... an additional family planning option. Sayana® Press has ... all levels of the health system and in ... widely used contraceptive—Pfizer’s Depo-Provera® (depot medroxyprogesterone acetate)—with the ... the first of four African countries expected to ...

(Date:7/10/2014)... Understanding the need for better quality and higher ... that currently exists in this area, ChanTest has recently ... validated ion channel and GPCR cell lines. ChanTest’s ... channels control many critical physiological functions throughout the body. ... to treat a variety of human diseases. , ...

(Date:7/10/2014)... Robert Harman, DVM, Founder and CEO of Vet-Stem, Inc., ... the relaunch of his highly informative blog, now named Stem ... What are Stem Cells ?” Dr. Harman’s purpose for ... the basics of stem cell therapy so that pet owners ... treatment when considering regenerative medicine. , A veterinarian by trade, ...

Breaking Biology Technology:Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 2 Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 3 Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 4 Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 2 Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 3 Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 4 Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 5 Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 6 Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2 Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3 Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2 Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3

[0] Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy [0] Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need [0] Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells [0] Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc.